Literature DB >> 2993305

Morphological transformation of Chinese hamster cells by acylpeptides, inhibitors of cAMP phosphodiesterase, produced by Bacillus subtilis.

K Hosono, H Suzuki.   

Abstract

Treatment of Chinese hamster ovary cells in vitro with acylpeptide, an inhibitor of adenosine 3':5'-cyclic monophosphate (cAMP) phosphodiesterase, produced by Bacillus subtilis C-756 converts the culture from one of randomly oriented, epithelial-like cells to one of elongated, fibroblast-like cells. This transformation is similar to the effect of N6,O2'-dibutyryl adenosine 3':5'-cyclic monophosphate (dibutyryl cAMP), but is manifested at a lower concentration of the inhibitor than with dibutyryl cAMP. The intracellular level of cAMP in the cells grown with the inhibitor is 3-4-fold higher than the level without the inhibitor. The transformation is reversible and, when reversed, the level of cAMP simultaneously decreases to the level without the inhibitor. The acylpeptide has cytolytic activity as well as inhibitory activity and the former activity is prevented by the addition of serum.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2993305

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  Cyclic AMP in prokaryotes.

Authors:  J L Botsford; J G Harman
Journal:  Microbiol Rev       Date:  1992-03

2.  Application of surfactin for mycoplasma inactivation in virus stocks.

Authors:  E Nissen; G Pauli; J Vater; D Vollenbroich
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-06       Impact factor: 2.416

Review 3.  Mechanisms of bacterial pathogenicity that involve production of calmodulin-sensitive adenylate cyclases.

Authors:  H R Masure; R L Shattuck; D R Storm
Journal:  Microbiol Rev       Date:  1987-03

4.  Bacterial effector binds host cell adenylyl cyclase to potentiate Gαs-dependent cAMP production.

Authors:  Arto T Pulliainen; Kathrin Pieles; Cameron S Brand; Barbara Hauert; Alex Böhm; Maxime Quebatte; Alexander Wepf; Matthias Gstaiger; Ruedi Aebersold; Carmen W Dessauer; Christoph Dehio
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-25       Impact factor: 11.205

5.  Antimycoplasma properties and application in cell culture of surfactin, a lipopeptide antibiotic from Bacillus subtilis.

Authors:  D Vollenbroich; G Pauli; M Ozel; J Vater
Journal:  Appl Environ Microbiol       Date:  1997-01       Impact factor: 4.792

6.  Dissociation of catalytic and invasive activities of Bordetella pertussis adenylate cyclase.

Authors:  A Raptis; L Knipling; J Wolff
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

7.  Zymosan activates protein kinase A via adenylyl cyclase VII to modulate innate immune responses during inflammation.

Authors:  Lily I Jiang; Paul C Sternweis; Jennifer E Wang
Journal:  Mol Immunol       Date:  2012-11-22       Impact factor: 4.407

Review 8.  Cyclic AMP: master regulator of innate immune cell function.

Authors:  Carlos H Serezani; Megan N Ballinger; David M Aronoff; Marc Peters-Golden
Journal:  Am J Respir Cell Mol Biol       Date:  2008-03-06       Impact factor: 6.914

9.  Bacillus bombysepticus α-Toxin Binding to G Protein-Coupled Receptor Kinase 2 Regulates cAMP/PKA Signaling Pathway to Induce Host Death.

Authors:  Ping Lin; Tingcai Cheng; Sanyuan Ma; Junping Gao; Shengkai Jin; Liang Jiang; Qingyou Xia
Journal:  PLoS Pathog       Date:  2016-03-29       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.